应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IAM Iambic Therapeutics
待上市 10-09 16:00:00 EDT
0.0000
+0.0000
--
最高
0.0000
最低
0.0000
成交量
0.00
今开
0.0000
昨收
0.0000
日振幅
0.00%
总市值
0.00
流通市值
0.00
总股本
4,740万
成交额
0.00
换手率
0.00%
流通股本
4,740万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
花旗维持DocuSign(DOCU.US)“中性”评级:IAM平台迁移初见效,两位数增长仍待“验票”
智通财经 · 10-09 18:58
花旗维持DocuSign(DOCU.US)“中性”评级:IAM平台迁移初见效,两位数增长仍待“验票”
小分子生物技术公司Iambic Therapeutics(IAM.US)IPO定价15-17美元/股 拟筹资1.5亿美元
智通财经 · 10-09 14:50
小分子生物技术公司Iambic Therapeutics(IAM.US)IPO定价15-17美元/股 拟筹资1.5亿美元
将零信任扩展到企业数据保护环境中
视频 · 2022-12-08
将零信任扩展到企业数据保护环境中
美国一铁路工会投票否决与铁路公司协议 将授权罢工
央视网 · 2022-09-15
美国一铁路工会投票否决与铁路公司协议 将授权罢工
公司概况
公司名称:
Iambic Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Iambic Therapeutics, Inc.于2019年10月在特拉华州注册成立,是一家技术和临床阶段生命科学公司,通过其分子超级智能平台寻求生物制药行业的根本转变,该平台将专有的大规模人工智能与自动化、可扩展的化学和生物学实验相结合。
发行价格:
--
{"stockData":{"symbol":"IAM","market":"US","secType":"STK","nameCN":"Iambic Therapeutics","latestPrice":0,"timestamp":1791576000000,"preClose":0,"halted":7,"volume":0,"delay":0,"floatShares":47400800,"shares":47400800,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"10-09 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792071000000},"marketStatusCode":8,"adr":0,"adrRate":0,"listingDate":1792036800000,"exchange":"NASDAQ","adjPreClose":0,"volumeRatio":0},"requestUrl":"/m/hq/s/IAM/wiki","defaultTab":"wiki","newsList":[{"id":"2674385658","title":"花旗维持DocuSign(DOCU.US)“中性”评级:IAM平台迁移初见效,两位数增长仍待“验票”","url":"https://stock-news.laohu8.com/highlight/detail?id=2674385658","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674385658?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:58","pubTimestamp":1791543503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4207","BK4566","LU0098860793.USD","LU0130102774.USD","LU1668664300.SGD","LU2462157665.USD","LU2456880835.USD","BK4613","IYF","LU0648001328.SGD","LU1244550221.USD","LU1506573853.SGD","BK4585","BK4528","LU0170899867.USD","BK4023","LU2360032135.SGD","LU1244550494.USD","LU0310800965.SGD","LU1244550577.SGD","LU0162691827.USD","LU1144417596.USD","LU2125154778.USD","LU2236285917.USD","TFNS","LU0130517989.USD","FTXO","LU1074936037.SGD","LU0203347892.USD","IAM","BK4559","BK4504","IE00BSNM7G36.USD","DOCU","LU0128525689.USD","LU0203345920.USD","LU1201861249.SGD","LU0477156953.USD","LU1366192091.USD","BK4534","BK4588","LU0106831901.USD","LU2417539215.USD","LU0980610538.SGD","LU0052756011.USD","LU1267930227.SGD","LU1791807156.HKD","LU0072461881.USD","LU0314106906.USD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674836788","title":"小分子生物技术公司Iambic Therapeutics(IAM.US)IPO定价15-17美元/股 拟筹资1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674836788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674836788?lang=zh_cn&edition=full","pubTime":"2026-10-09 14:50","pubTimestamp":1791528639,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,依托自研人工智能平台开发小分子抗癌疗法、处于一期临床阶段的生物技术公司Iambic Therapeutics于周四公布了其IPO条款。按拟发行价区间中值计算,Iambic Therapeutics的完全摊薄市值将达到8.09亿美元。据了解,Iambic Therapeutics是一家临床阶段的生物技术公司,将专有AI模型与自动化高通量化学和生物学相结合,用于设计小分子药物。Iambic Therapeutics成立于2019年,截至2026年6月30日的过去12个月实现营收1800万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HELX","IPOS","UUP","IAM","LENZ","UDN","BK4539","WDNA","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2289413490","title":"将零信任扩展到企业数据保护环境中","url":"https://stock-news.laohu8.com/highlight/detail?id=2289413490","media":"视频","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2289413490?lang=zh_cn&edition=full","pubTime":"2022-12-08 14:33","pubTimestamp":1670481234,"startTime":"0","endTime":"0","summary":"文/ Veritas公司大中华区总裁 滕文勒索攻击的案例正在全球范围内激增。即便企业加强了前端安全,潜伏在远程办公和复杂的多云环境中的黑客们还是花样百出,可谓道高一尺魔高一丈。如今,像网络钓鱼这样的传统攻击手法和更复杂的针对物联网设备、云服务和数据,以及基础设施漏...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.zol.com.cn/808/8086694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zol_stock","symbols":["MFA","BK4110","RBAC","IAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2267579857","title":"美国一铁路工会投票否决与铁路公司协议 将授权罢工","url":"https://stock-news.laohu8.com/highlight/detail?id=2267579857","media":"央视网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2267579857?lang=zh_cn&edition=full","pubTime":"2022-09-15 00:14","pubTimestamp":1663172065,"startTime":"0","endTime":"0","summary":"当地时间9月14日,据美国当地媒体报道,美国国际机械师和航空航天工人协会 的近5000名铁路工人投票否决了与美国最大的货运铁路公司达成的协议,并授权进行罢工。据悉,一旦开始罢工,近30%的美国货物发货将被迫停止,通胀将进一步恶化,本就脆弱的供应链将面临巨大的打击。美国总统拜登和其他高级政府官员正在与工会和货运铁路公司进行协商,以避免即将到来的罢工,防止罢工在中期选举前几周扰乱美国经济。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina_symbol","url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-09-15/doc-imqqsmrn9114726.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.extra-info, .source{#sourceStyle#;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/jjxw/2022-09-15/doc-imqqsmrn9114726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_symbol","symbols":["IAM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iambic.ai","compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Iambic Therapeutics, Inc.于2019年10月在特拉华州注册成立,是一家技术和临床阶段生命科学公司,通过其分子超级智能平台寻求生物制药行业的根本转变,该平台将专有的大规模人工智能与自动化、可扩展的化学和生物学实验相结合。","exchange":"NASDAQ","name":"Iambic Therapeutics","nameEN":"Iambic Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Iambic Therapeutics(IAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Iambic Therapeutics(IAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Iambic Therapeutics,IAM,Iambic Therapeutics股票,Iambic Therapeutics股票老虎,Iambic Therapeutics股票老虎国际,Iambic Therapeutics行情,Iambic Therapeutics股票行情,Iambic Therapeutics股价,Iambic Therapeutics股市,Iambic Therapeutics股票价格,Iambic Therapeutics股票交易,Iambic Therapeutics股票购买,Iambic Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Iambic Therapeutics(IAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Iambic Therapeutics(IAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}